Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta

G. S. McGee, Bernard Timothy Baxter, V. P. Shively, R. Chisholm, W. J. McCarthy, W. R. Flinn, J. S T Yao, W. H. Pearce

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Atherosclerosis of the infrarenal aorta results in distinct clinical entities-aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Although loss of collagen has been implicated in AAA, collagen accumulation plays a role in AOD. In vivo collagen-gene expression can be assessed using complementary DNA for collagen types I and III α-chains. The purpose of this study is to compare total collagen (type I + III) and collagen types I and III messenger RNA in AAA, AOD and normal aorta. Specimens were collected from the infrarenal aorta during operation for AOD (n = 7), AAA (n = 7), autopsy, or organ procurement (normal; n = 7). Northern transfer analysis of total RNA was used to compare mRNA levels for type I and III collagen. After preliminary extraction, specimens were hydrolyzed for hydroxyproline analysis used to calculate total collagen (type I + III). Relative levels of type I (pro-a1 [1]) mRNA were greater in both AOD (0.77 ± 0.35) and AAA tissue (0.94 ± 0.24; p = 0.6) than in normal aorta (0.02 ± 0.03). Type III (pro-a1 [III]) mRNA levels were also greater in AOD (2.52 ± 0.19; p = 0.09) and AAA tissue (3.15 ± 1.3) than in normals (0.97 ± 0.47). Total collagen concentration was increased in AOD (45.6% ± 3.1% dry weight; p < 0.05) but not AAA tissue (27.8% ± 4%) when compared to normal aorta (34.7% ± 2.3%). Collagen type I and III gene expression is greater in older, diseased aorta, yet collagen accumulated only in AOD. This implies a similar synthetic response in both AOD and AAA. Thus, proteolytic degradation in AAA appears to determine collagen content and possibly the clinical course of the atherosclerotic process.

Original languageEnglish (US)
Pages (from-to)370-376
Number of pages7
JournalSurgery
Volume110
Issue number2
StatePublished - Dec 1 1991

Fingerprint

Abdominal Aortic Aneurysm
Aneurysm
Aorta
Atherosclerosis
Collagen Type III
Collagen Type I
Collagen
Messenger RNA
Gene Expression
Tissue and Organ Procurement
Hydroxyproline
Autopsy
Complementary DNA
RNA
Weights and Measures

ASJC Scopus subject areas

  • Surgery

Cite this

McGee, G. S., Baxter, B. T., Shively, V. P., Chisholm, R., McCarthy, W. J., Flinn, W. R., ... Pearce, W. H. (1991). Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta. Surgery, 110(2), 370-376.

Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta. / McGee, G. S.; Baxter, Bernard Timothy; Shively, V. P.; Chisholm, R.; McCarthy, W. J.; Flinn, W. R.; Yao, J. S T; Pearce, W. H.

In: Surgery, Vol. 110, No. 2, 01.12.1991, p. 370-376.

Research output: Contribution to journalArticle

McGee, GS, Baxter, BT, Shively, VP, Chisholm, R, McCarthy, WJ, Flinn, WR, Yao, JST & Pearce, WH 1991, 'Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta', Surgery, vol. 110, no. 2, pp. 370-376.
McGee GS, Baxter BT, Shively VP, Chisholm R, McCarthy WJ, Flinn WR et al. Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta. Surgery. 1991 Dec 1;110(2):370-376.
McGee, G. S. ; Baxter, Bernard Timothy ; Shively, V. P. ; Chisholm, R. ; McCarthy, W. J. ; Flinn, W. R. ; Yao, J. S T ; Pearce, W. H. / Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta. In: Surgery. 1991 ; Vol. 110, No. 2. pp. 370-376.
@article{c26b5c7dc7fe41ae9e898e0a2c361f3f,
title = "Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta",
abstract = "Atherosclerosis of the infrarenal aorta results in distinct clinical entities-aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Although loss of collagen has been implicated in AAA, collagen accumulation plays a role in AOD. In vivo collagen-gene expression can be assessed using complementary DNA for collagen types I and III α-chains. The purpose of this study is to compare total collagen (type I + III) and collagen types I and III messenger RNA in AAA, AOD and normal aorta. Specimens were collected from the infrarenal aorta during operation for AOD (n = 7), AAA (n = 7), autopsy, or organ procurement (normal; n = 7). Northern transfer analysis of total RNA was used to compare mRNA levels for type I and III collagen. After preliminary extraction, specimens were hydrolyzed for hydroxyproline analysis used to calculate total collagen (type I + III). Relative levels of type I (pro-a1 [1]) mRNA were greater in both AOD (0.77 ± 0.35) and AAA tissue (0.94 ± 0.24; p = 0.6) than in normal aorta (0.02 ± 0.03). Type III (pro-a1 [III]) mRNA levels were also greater in AOD (2.52 ± 0.19; p = 0.09) and AAA tissue (3.15 ± 1.3) than in normals (0.97 ± 0.47). Total collagen concentration was increased in AOD (45.6{\%} ± 3.1{\%} dry weight; p < 0.05) but not AAA tissue (27.8{\%} ± 4{\%}) when compared to normal aorta (34.7{\%} ± 2.3{\%}). Collagen type I and III gene expression is greater in older, diseased aorta, yet collagen accumulated only in AOD. This implies a similar synthetic response in both AOD and AAA. Thus, proteolytic degradation in AAA appears to determine collagen content and possibly the clinical course of the atherosclerotic process.",
author = "McGee, {G. S.} and Baxter, {Bernard Timothy} and Shively, {V. P.} and R. Chisholm and McCarthy, {W. J.} and Flinn, {W. R.} and Yao, {J. S T} and Pearce, {W. H.}",
year = "1991",
month = "12",
day = "1",
language = "English (US)",
volume = "110",
pages = "370--376",
journal = "Surgery (United States)",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Aneurysm or occlusive disease - Factors determining the clinical course of atherosclerosis of the infrarenal aorta

AU - McGee, G. S.

AU - Baxter, Bernard Timothy

AU - Shively, V. P.

AU - Chisholm, R.

AU - McCarthy, W. J.

AU - Flinn, W. R.

AU - Yao, J. S T

AU - Pearce, W. H.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Atherosclerosis of the infrarenal aorta results in distinct clinical entities-aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Although loss of collagen has been implicated in AAA, collagen accumulation plays a role in AOD. In vivo collagen-gene expression can be assessed using complementary DNA for collagen types I and III α-chains. The purpose of this study is to compare total collagen (type I + III) and collagen types I and III messenger RNA in AAA, AOD and normal aorta. Specimens were collected from the infrarenal aorta during operation for AOD (n = 7), AAA (n = 7), autopsy, or organ procurement (normal; n = 7). Northern transfer analysis of total RNA was used to compare mRNA levels for type I and III collagen. After preliminary extraction, specimens were hydrolyzed for hydroxyproline analysis used to calculate total collagen (type I + III). Relative levels of type I (pro-a1 [1]) mRNA were greater in both AOD (0.77 ± 0.35) and AAA tissue (0.94 ± 0.24; p = 0.6) than in normal aorta (0.02 ± 0.03). Type III (pro-a1 [III]) mRNA levels were also greater in AOD (2.52 ± 0.19; p = 0.09) and AAA tissue (3.15 ± 1.3) than in normals (0.97 ± 0.47). Total collagen concentration was increased in AOD (45.6% ± 3.1% dry weight; p < 0.05) but not AAA tissue (27.8% ± 4%) when compared to normal aorta (34.7% ± 2.3%). Collagen type I and III gene expression is greater in older, diseased aorta, yet collagen accumulated only in AOD. This implies a similar synthetic response in both AOD and AAA. Thus, proteolytic degradation in AAA appears to determine collagen content and possibly the clinical course of the atherosclerotic process.

AB - Atherosclerosis of the infrarenal aorta results in distinct clinical entities-aortoiliac occlusive disease (AOD) and abdominal aortic aneurysm (AAA). Although loss of collagen has been implicated in AAA, collagen accumulation plays a role in AOD. In vivo collagen-gene expression can be assessed using complementary DNA for collagen types I and III α-chains. The purpose of this study is to compare total collagen (type I + III) and collagen types I and III messenger RNA in AAA, AOD and normal aorta. Specimens were collected from the infrarenal aorta during operation for AOD (n = 7), AAA (n = 7), autopsy, or organ procurement (normal; n = 7). Northern transfer analysis of total RNA was used to compare mRNA levels for type I and III collagen. After preliminary extraction, specimens were hydrolyzed for hydroxyproline analysis used to calculate total collagen (type I + III). Relative levels of type I (pro-a1 [1]) mRNA were greater in both AOD (0.77 ± 0.35) and AAA tissue (0.94 ± 0.24; p = 0.6) than in normal aorta (0.02 ± 0.03). Type III (pro-a1 [III]) mRNA levels were also greater in AOD (2.52 ± 0.19; p = 0.09) and AAA tissue (3.15 ± 1.3) than in normals (0.97 ± 0.47). Total collagen concentration was increased in AOD (45.6% ± 3.1% dry weight; p < 0.05) but not AAA tissue (27.8% ± 4%) when compared to normal aorta (34.7% ± 2.3%). Collagen type I and III gene expression is greater in older, diseased aorta, yet collagen accumulated only in AOD. This implies a similar synthetic response in both AOD and AAA. Thus, proteolytic degradation in AAA appears to determine collagen content and possibly the clinical course of the atherosclerotic process.

UR - http://www.scopus.com/inward/record.url?scp=0026331054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026331054&partnerID=8YFLogxK

M3 - Article

C2 - 1858045

AN - SCOPUS:0026331054

VL - 110

SP - 370

EP - 376

JO - Surgery (United States)

JF - Surgery (United States)

SN - 0039-6060

IS - 2

ER -